// App-Quantinova.ai

9554 : Minimal residual disease by flow cytometry at the end of chemotherapy for remission induction in pediatric patients with acute lymphoblastic leukemia: Experience from a center in a low-income country.

Researchers

Presenter

  • Eloy Perez

Principal Investigators

  • Primo Cruz-Borja

  • Silvia Chavez-Gallegos

Medical Centers

  • Hospital Infantil de Morelia Eva Samano de Lopez Mateos, Morelia, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved